RLYB

15.5900.45%
SU

Stephen Uden

Co-Founder, President, CEO & Director

Dr. Stephen Uden, also known as Steve, MD, MBBS, is Chief Executive Officer and Director of Rallybio, LLC since August 01, 2023 and serves as its President. Dr. Uden is a Co-Founder of Rallybio, LLC in 2018 and served as its Chief Operating Officer until August 01, 2023. Dr. Uden is the Co-Founder of Rallybio Corporation and has been its President, Chief Executive Officer and Director since August 01, 2023 and served as Chief Operating Officer and Chief Scientific Officer since January 2018 until August 01, 2023. Previously, Dr. Uden served as Senior Vice President, Research at Alexion from June 2014 to October 2017 Dr. Uden served as Executive Vice President and Head of Research & Development of Neurogen Corp. since June 2005. Prior to joining Neurogen, Dr. Uden served as Vice President of Development, Site Head for Pfizer Global Research & Development in New London, Connecticut. He began his career with the United Kingdom's National Health Service, practicing internal medicine with a specialty in gastroenterology. He started with Pfizer in 1989 and was promoted through a series of positions of increasing responsibility in the United Kingdom before moving to Japan, where he served as Vice President, Head of Clinical Research for Pfizer Japan. Dr. Uden's accomplishments include involvement in global filings for Pfizer's migraine drug Relpax(R)(eletriptan) and for its atrial fibrillation drug, Tikosyn(R)(dofetilide), as well as Zoloft(R), Neurontin(R)and Diflucan(R)prodrug in Japan. Dr. Uden earned a BSc in biochemistry from the University of London. Dr. Uden holds MBBS degree in Medicine from St. Thomas' Medical School, University of London, is a Member of the Royal College of Physicians and served as an Officer in the Territorial Army (UK reserve military force) reaching the rank of Major.

Positions